Experimental Weight-Loss Tablet Shows Promise

Published on March 27, 2024

Viking Therapeutics’ experimental tablet reduced weight by as much as 3.3% when tested in volunteers enrolled in a small early-stage trial, meeting Wall Street expectations and sending the company’s shares up 15% in premarket trading on Tuesday. Popular market leaders from…

Read Full Article (External Site)